Skip to main content
Message Font: Serif | Sans-Serif
 
No. of Recommendations: 1
hi Rich

I like to look at price to EBITDA but there is no clue here what that might be.

maybe if we add 16¢ to ttm EPS and apply a PE to that it looks better?

I get $2.70 with the 16¢ at high end and the PE at 18--lower than LDR is
now.

The products they are acquiring seem like a good fit and the consumable nature is a plus. The high percentage of sales to hospitals and clinics would be a concern if these were capital intense products. They are likely fairly cheap and used every day and if the customer has a relationship with IZI and likes the product, sales should continue even after LDR takes them over.

The one thing that gives me pause is the $175 million debt. LDR has not had this high a debt level that I can see over the past 8 years. Don't know how easily it will be handled along with the dividends. Won't know all the details I guess until it's done

Generally, looks like a good addition to give LDR some growth. Without acquisitions, dosimetry will never give them much in the way of growth--too mature. I actually didn't mind that and was happy just to collect the dividend
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.